NanoSanguis, Inc.

NanoSanguis, Inc. NanoSanguis is a company founded to bring to the market first safe and effective red blood cell substitute. The company has its origin in Warsaw University

NanoSanguis is an unique niche where the advanced science meets practical application experience and professional business. The company has its origin in Warsaw University of Technology – the cluster of excellence in polish innovative commercialization. We have started as a team of PhD candidates developing technology of oxygen therapeutics. In December 2015, together with two VC capitals – Start

Venture Poland and Giza Polish Ventures, we founded NanoSanguis to bring to the market first safe and effective red blood cell substitute.

Adres

Warsaw
O2-532

Strona Internetowa

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy NanoSanguis, Inc. umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Firmę

Wyślij wiadomość do NanoSanguis, Inc.:

Skróty

Udostępnij